Design of a novel mutant human coagulation protein as a new anticoagulant drug, and as a tool for investigating the activity and regulation key enzymes in blood coagulation.
Design of a novel mutant human coagulation protein as a new anticoagulant drug, and as a tool for investigating the activity and regulation key enzymes in blood coagulation.
设计一种新型突变人类凝血蛋白作为新型抗凝血药物，并作为研究凝血中关键酶的活性和调节的工具。
批准号：
283889
负责人：
Yeh Calvin H
金额：
$7.65万
依托单位：
依托单位国家：
加拿大
项目类别：
Studentship Programs
财政年份：
2012
资助国家：
加拿大
项目状态：
已结题
起止时间：
2012-10-01 至 2015-10-01
中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Heart attacks and strokes, the number one cause of death and disability in Canada, are often caused by defective blood clotting in the human body. This research project aims to translate discoveries made on the scientific bench to the bedside, by figuring
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The BEACONS Platform - Comprehensive biomarker analysis for prediction of clinical course and management in acute coagulopathy in sepsis, trauma, cardiac arrest, and COVID-19
-
批准号：454967
-
项目类别：Fellowship Programs
-
资助金额：$12.02万
-
财政年份：2021
-
负责人：Yeh Calvin H
-
依托单位：
Development of a mutant human coagulation protein as a novel antidote for new direct factor Xa anticoagulant drugs, and as a tool for investigating the activity and regulation of intrinsic and extrinsic tenase, key enzyme complexes in blood coagulation.
-
批准号：278235
-
项目类别：
-
资助金额：$0.04万
-
财政年份：2013
-
负责人：Yeh Calvin H
-
依托单位：
FIXa protection from heparin-antithrombin inhibition when incorporated into the intrisic tenase complex
-
批准号：199647
-
项目类别：Studentship Programs
-
资助金额：$1.27万
-
财政年份：2010
-
负责人：Yeh Calvin H
-
依托单位：
海外基金
